Skip to main content

US District Court Dismisses Patent-Infringement Suit Against ABI, PerkinElmer

NEW YORK, April 3 - Applied Biosystems today said that the US District Court for the District of Connecticut has dismissed "all claims" brought by On-Line Technologies against ABI, PerkinElmer, and Sick.

According to ABI, On-Line filed the suit in early November 1999 claiming that these companies infringed a patent and misappropriated a trade secret, "among other things," related to products manufactured by former divisions of ABI that were sold to PerkinElmer and Sick.

 

On-Line Technologies, which has since been acquired by MKS Instruments, filed claims for "patent infringement, trade secret misappropriation, fraud, breach of contract, and unfair trade practices against Applera, PerkinElmer, and Sick," ABI spokeswoman Lori Murray said in an e-mail to GenomeWeb.

The complaint argued that products called Spectrum One and MCS100E, which were made by former ABI division that later were sold to PerkinElmer and Sick, "were based on allegedly proprietary information belonging to On-Line Technologies and that the MCS100E infringed U.S. Patent No. 5,440,143. The case was actually dismissed March 31.

 

Officials from MKS Instruments did not return a telephone call seeking comment. A PerkinElmer spokesman declined to comment.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.